Skip to main content
. 2014 Sep-Oct;19(5):241–250. doi: 10.1155/2014/760145

TABLE 5.

Needs and preferences of physicians and pharmacists regarding the format and content of a continuing education program (CEP) for chronic noncancer pain (CNCP) and its treatment

Pharmacists (n=109) Physicians (n=136)
From your standpoint, is there a need for a CEP in CNCP for primary care physicians (or pharmacists)?
  Yes 109 (100) 136 (100)
What would be the best educational vehicle(s) or method(s) for a CEP?
  Interactive activities or courses (PBL) 52 (47.7) 89 (65.4)
  Self-learning modules (paper format) 51 (46.8) 48 (35.5)
  Scientific presentations by peers 45 (41.3) 55 (40.4)
  Self-learning modules (Internet based) 37 (33.9) 58 (42.6)
  Formal lectures 34 (31.2) 49 (36.0)
  Training days in a pain management clinic 31 (28.4) 37 (27.2)
  Other 0 (0.0) 10 (7.4)
In which area(s) would you like to have more training with regard to CNCP?
  Review of Canadian and/or Quebec guideline recommendations 84 (77.1) 64 (47.1)
  Indication and use of:
    Anticonvulsants 70 (64.2) 41 (30.1)
    Antidepressants 67 (61.5) 38 (27.9)
    Opioids 66 (60.6) 42 (30.9)
    NSAIDs and coxibs 53 (48.6) 25 (18.4)
Pharmacists’ specific topics
  Detection and management of drug-related problems 61 (56.0)
  Pharmaceutical care with analgesic dose adjustment 59 (54.1)
  Nonpharmacological methods to manage chronic pain 58 (53.2)
  Detection and management of side effects 43 (39.4)
  Physician-pharmacist workshop on collaborative practices 41 (37.6)
  Diagnosis update 30 (27.5)
Physicians’ specific topics
  Differential diagnoses of chronic pain syndromes 97 (71.3)
  Trigger-point-injection intervention techniques; joint or muscle infiltration 61 (44.9)
  Psychological techniques for chronic pain 55 (40.4)
  Indication and referral procedure for patient to a multidisciplinary pain management clinic 55 (40.4)
  Physical assessment of patient 50 (36.8)
  Psychological assessment of patient 44 (32.4)
  Psychological follow-up of patient 41 (30.1)
  Physical follow-up of patient 36 (26.5)
  Physical treatment techniques for chronic pain 35 (25.7)
  Radiological assessment of patient 24 (17.6)
  Other 9 (6.6)

Data presented as n (%). Coxib Selective cyclooxygenase-2 inhibitor; NSAID Nonsteroidal anti-inflammatory drug; PBL Problem-based learning